Personal information

Emails & domains

Verified email domains

Other IDs

Loop profile: 1016794
Scopus Author ID: 57220456896

Activities

Collapse all

Employment (1)

Leiden University Medical Center: Leiden, NL

Employment
Source: Self-asserted source
Jan Pieter Koopman

Education and qualifications (3)

London School of Hygiene and Tropical Medicine: London, GB

2018 to 2019 | MSc Epidemiology
Education
Source: Self-asserted source
Jan Pieter Koopman

Leiden University: Leiden, NL

2013 to 2018 | MSc Medicine
Education
Source: Self-asserted source
Jan Pieter Koopman

Leiden University: Leiden, NL

2010 to 2013 | BSc Medicine
Education
Source: Self-asserted source
Jan Pieter Koopman

Works (34)

T cell responses in repeated controlled human schistosome infection compared to natural exposure

2025-02-17 | Preprint
DOI: 10.1101/2025.02.13.25322130
Contributors: Emmanuella Driciru; Jan Pieter R. Koopman; Sanne Steenbergen; Friederike Sonnet; Koen A. Stam; Helena de Bes-Roeleveld; Eva Iliopoulou; Jacqueline J. Janse; Jeroen Sijtsma; Irene Nambuya et al.
Source: check_circle
Crossref

Single immunization with genetically attenuated Pf∆mei2 (GA2) parasites by mosquito bite in controlled human malaria infection: a placebo-controlled randomized trial

Nature Medicine
2025-01 | Journal article
DOI: 10.1038/s41591-024-03347-2
Contributors: Geert V. T. Roozen; Roos van Schuijlenburg; Annefleur D. O. Hensen; Jan Pieter R. Koopman; Olivia A. C. Lamers; Fiona J. A. Geurten; Jeroen C. Sijtsma; Els Baalbergen; Jacqueline J. Janse; Séverine Chevalley-Maurel et al.
Source: check_circle
Crossref

Clinical tolerance but no protective efficacy in a placebo-controlled trial of repeated controlled schistosome infection.

The Journal of clinical investigation
2024-12 | Journal article
DOI: 10.1172/jci185422
PMID: 39666392
Contributors: Koopman JPR; Houlder EL; Janse JJ; Lamers OA; Roozen GV; Sijtsma JC; Casacuberta-Partal M; Hilt ST; van der Stoep MYEC; van Amerongen-Westra IM et al.
Source: Self-asserted source
Jan Pieter Koopman via Europe PubMed Central

Safety and Efficacy of Immunization with a Late-Liver-Stage Attenuated Malaria Parasite.

The New England journal of medicine
2024-11 | Journal article
DOI: 10.1056/nejmoa2313892
PMID: 39565990
Contributors: Lamers OAC; Franke-Fayard BMD; Koopman JPR; Roozen GVT; Janse JJ; Chevalley-Maurel SC; Geurten FJA; de Bes-Roeleveld HM; Iliopoulou E; Colstrup E et al.
Source: Self-asserted source
Jan Pieter Koopman via Europe PubMed Central

Rabies knowledge gaps and risk behaviour in Dutch travellers: An observational cohort study.

Travel medicine and infectious disease
2024-07 | Journal article
DOI: 10.1016/j.tmaid.2024.102739
PMID: 39009201
Contributors: Overduin LA; Koopman JPR; Prins C; Verbeek-Menken PH; de Pijper CA; Heerink F; van Genderen PJJ; Grobusch MP; Visser LG
Source: Self-asserted source
Jan Pieter Koopman via Europe PubMed Central

Early symptom-associated inflammatory responses shift to type 2 responses in controlled human schistosome infection

Science Immunology
2024-07-05 | Journal article
DOI: 10.1126/sciimmunol.adl1965
Contributors: Emma L. Houlder; Koen A. Stam; Jan Pieter R. Koopman; Marion H. König; Marijke C. C. Langenberg; Marie-Astrid Hoogerwerf; Paula Niewold; Friederike Sonnet; Jacqueline J. Janse; Miriam Casacuberta Partal et al.
Source: check_circle
Crossref

Intradermal delivery of the third dose of the mRNA-1273 SARS-CoV-2 vaccine: safety and immunogenicity of a fractional booster dose.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
2024-03 | Journal article
DOI: 10.1016/j.cmi.2024.03.028
PMID: 38552793
Contributors: Roozen GVT; Prins MLM; Prins C; Janse JJ; de Gruyter HLM; Pothast CR; Huisman W; Koopman JPR; Lamers OAC; Kuijer M et al.
Source: Self-asserted source
Jan Pieter Koopman via Europe PubMed Central

Immunogenicity and reactogenicity of intradermal mRNA-1273 SARS-CoV-2 vaccination: a non-inferiority, randomized-controlled trial.

NPJ vaccines
2024-01 | Journal article
DOI: 10.1038/s41541-023-00785-w
PMID: 38167735
PMC: PMC10761693
Contributors: Prins MLM; Roozen GVT; Pothast CR; Huisman W; van Binnendijk R; den Hartog G; Kuiper VP; Prins C; Janse JJ; Lamers OAC et al.
Source: Self-asserted source
Jan Pieter Koopman via Europe PubMed Central

Protective efficacy of short-term infection with Necator americanus hookworm larvae in healthy volunteers in the Netherlands: a single-centre, placebo-controlled, randomised, controlled, phase 1 trial.

The Lancet. Microbe
2023-12 | Journal article
DOI: 10.1016/s2666-5247(23)00218-5
PMID: 38042152
Contributors: Hoogerwerf MA; Janse JJ; Kuiper VP; van Schuijlenburg R; Kruize YC; Sijtsma JC; Nosoh BA; Koopman JR; Verbeek-Menken PH; Westra IM et al.
Source: Self-asserted source
Jan Pieter Koopman via Europe PubMed Central

Safety and infectivity of female cercariae in Schistosoma-naïve, healthy participants: a controlled human Schistosoma mansoni infection study

eBioMedicine
2023-11 | Journal article
DOI: 10.1016/j.ebiom.2023.104832
Contributors: Jan Pieter R. Koopman; Emma L. Houlder; Jacqueline J. Janse; Miriam Casacuberta-Partal; Olivia A.C. Lamers; Jeroen C. Sijtsma; Claudia de Dood; Stan T. Hilt; Arifa Ozir-Fazalalikhan; Vincent P. Kuiper et al.
Source: check_circle
Crossref

Boostability after single-visit pre-exposure prophylaxis with rabies vaccine: a randomised controlled non-inferiority trial.

The Lancet. Infectious diseases
2023-10 | Journal article
DOI: 10.1016/s1473-3099(23)00452-8
PMID: 37802090
Contributors: Overduin LA; Koopman JPR; Prins C; Verbeek-Menken PH; De Pijper CA; Eblé PL; Heerink F; van Genderen PJJ; Grobusch MP; Visser LG
Source: Self-asserted source
Jan Pieter Koopman via Europe PubMed Central

Human infection challenge in the pandemic era and beyond, HIC-Vac annual meeting report, 2022.

Immunotherapy advances
2023-10 | Journal article
DOI: 10.1093/immadv/ltad024
PMID: 38020312
PMC: PMC10640868
Contributors: Barnes MVC; Mandla A; Smith E; Maskuniitty M; Openshaw PJM; HIC-Vac meeting contributors
Source: Self-asserted source
Jan Pieter Koopman via Europe PubMed Central

Changes in pro inflammatory and regulatory immune responses during controlled human schistosome infection and the development of clinical symptoms

2023-09-04 | Preprint
DOI: 10.1101/2023.09.01.23294933
Contributors: Emma L. Houlder; Koen A. Stam; Jan Pieter R. Koopman; Marion H. König; Marijke C.C. Langenberg; Marie-Astrid Hoogerwerf; Paula Niewold; Friederike Sonnet; Jacqueline J. Janse; Miriam Casacuberta Partal et al.
Source: check_circle
Crossref

Causal chemoprophylactic activity of cabamiquine against Plasmodium falciparum in a controlled human malaria infection: a randomised, double-blind, placebo-controlled study in the Netherlands.

The Lancet. Infectious diseases
2023-07 | Journal article
DOI: 10.1016/s1473-3099(23)00212-8
PMID: 37414066
Contributors: van der Plas JL; Kuiper VP; Bagchus WM; Bödding M; Yalkinoglu Ö; Tappert A; Seitzinger A; Spangenberg T; Bezuidenhout D; Wilkins J et al.
Source: Self-asserted source
Jan Pieter Koopman via Europe PubMed Central

Uganda Schistosomiasis Symposium 2023: understanding morbidity drivers and developing controlled human infection models for vaccine research

Trends in Parasitology
2023-07 | Journal article
DOI: 10.1016/j.pt.2023.03.017
Contributors: Moses Egesa; Davis Kiberu; Richard E. Sanya; Ayodele Alabi; Friederike Sonnet; Jan Pieter R. Koopman; Joseph Baruch Baluku; David W. Oguttu; Emmanuella Driciru; Matthew Odongo et al.
Source: check_circle
Crossref

Establishing a Single-Sex Controlled Human <i>Schistosoma mansoni</i> Infection Model for Uganda: Protocol for Safety and Dose-Finding Trial

Immunotherapy Advances
2023-07-20 | Journal article
DOI: 10.1093/immadv/ltad010
Part of ISSN: 2732-4303
Contributors: Andrew Abaasa; Moses Egesa; Emmanuella Driciru; Jan Pieter R Koopman; Ronald Kiyemba; Richard E Sanya; Jacent Nassuuna; Agnes Ssali; Geofrey Kimbugwe; Anne Wajja et al.
Source: Self-asserted source
Jan Pieter Koopman

Pulmonary inflammation promoted by type-2 dendritic cells is a feature of human and murine schistosomiasis

Nature Communications
2023-04-03 | Journal article
DOI: 10.1038/s41467-023-37502-z
Contributors: E. L. Houlder; A. H. Costain; I. Nambuya; S. L. Brown; J. P. R. Koopman; M. C. C. Langenberg; J. J. Janse; M. A. Hoogerwerf; A. J. L. Ridley; J. E. Forde-Thomas et al.
Source: check_circle
Crossref

A comparison of two Fendrix hepatitis B vaccination schedules in patients with inflammatory bowel disease.

Vaccine
2022-09 | Journal article
DOI: 10.1016/j.vaccine.2022.09.006
PMID: 36154758
Contributors: Kuiper VP; van der Plas P; Hoogerwerf MA; Pieter R Koopman J; van der Meulen AE; Roukens AHE; Visser LG; Roestenberg M
Source: Self-asserted source
Jan Pieter Koopman via Europe PubMed Central
grade
Preferred source (of 2)‎

Intestinal permeability before and after albendazole treatment in low and high socioeconomic status schoolchildren in Makassar, Indonesia.

Scientific reports
2022-03 | Journal article
DOI: 10.1038/s41598-022-07086-7
PMID: 35233023
PMC: PMC8888571
Contributors: Amaruddin AI; Koopman JPR; Muhammad M; Lenaerts K; van Eijk HMH; Brienen EAT; Geelen AR; van Lieshout L; Wahyuni S; Kuijper EJ et al.
Source: Self-asserted source
Jan Pieter Koopman via Europe PubMed Central
grade
Preferred source (of 2)‎

Excretion patterns of <i>Schistosoma mansoni</i> antigens CCA and CAA by adult male and female worms, using a mouse model and <i>ex vivo</i> parasite cultures.

Parasitology
2021-11 | Journal article
DOI: 10.1017/s0031182021001839
PMID: 34736550
Contributors: Casacuberta-Partal M; van Lieshout L; van Diepen A; Sijtsma JC; Ozir-Fazalalikhan A; Koopman JPR; de Dood CJ; Corstjens PLAM; van Dam GJ; Hokke CH et al.
Source: Self-asserted source
Jan Pieter Koopman via Europe PubMed Central
grade
Preferred source (of 2)‎

Controlled human infection models to evaluate schistosomiasis and hookworm vaccines: where are we now?

Expert Review of Vaccines
2021-11-02 | Journal article
DOI: 10.1080/14760584.2021.1951244
Contributors: Jan Pieter R. Koopman; Emmanuella Driciru; Meta Roestenberg
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

The determinants of lipid profiles in early adolescence in a Ugandan birth cohort.

Scientific reports
2021-08 | Journal article
DOI: 10.1038/s41598-021-96035-x
PMID: 34389769
PMC: PMC8363641
Contributors: Koopman JPR; Lule SA; Zziwa C; Akurut H; Lubyayi L; Nampijja M; Akello F; Balungi P; Tumusiime J; Oduru G et al.
Source: Self-asserted source
Jan Pieter Koopman via Europe PubMed Central
grade
Preferred source (of 2)‎

[Controlled human infection studies: efficient research on tropical infectious diseases].

Nederlands tijdschrift voor geneeskunde
2021-07 | Journal article
PMID: 34346621
Contributors: Koopman JPR; Kuiper VP; Hoogerwerf MA
Source: Self-asserted source
Jan Pieter Koopman via Europe PubMed Central

Bee- and Wasp-Venom Sensitization in Schoolchildren of High- and Low-Socioeconomic Status Living in an Urban Area of Indonesia.

International archives of allergy and immunology
2021-05 | Journal article
DOI: 10.1159/000516155
PMID: 33951631
Contributors: Amaruddin AI; Koopman JPR; Muhammad M; Versteeg SA; Wahyuni S; van Ree R; Yazdanbakhsh M; Hamid F; Sartono E
Source: Self-asserted source
Jan Pieter Koopman via Europe PubMed Central
grade
Preferred source (of 2)‎

Immunological Considerations for <i>Schistosoma</i> Vaccine Development: Transitioning to Endemic Settings.

Frontiers in immunology
2021-03 | Journal article
DOI: 10.3389/fimmu.2021.635985
PMID: 33746974
PMC: PMC7970007
Contributors: Driciru E; Koopman JPR; Cose S; Siddiqui AA; Yazdanbakhsh M; Elliott AM; Roestenberg M
Source: Self-asserted source
Jan Pieter Koopman via Europe PubMed Central
grade
Preferred source (of 2)‎

The relationship between malnutrition and T<sub>H</sub> 2 immune markers: a study in school-aged children of different socio-economic backgrounds in Makassar, Indonesia.

Tropical medicine & international health : TM & IH
2020-11 | Journal article
DOI: 10.1111/tmi.13513
PMID: 33164283
Contributors: Wahyuni S; van Dorst MMAR; Amaruddin AI; Muhammad M; Yazdanbakhsh M; Hamid F; Koopman JPR; Sartono E
Source: Self-asserted source
Jan Pieter Koopman via Europe PubMed Central
grade
Preferred source (of 2)‎

Dynamics of the bacterial gut microbiota during controlled human infection with Necator americanus larvae

Gut Microbes
2020-11-09 | Journal article
DOI: 10.1080/19490976.2020.1840764
Contributors: Q. R. Ducarmon; M. A. Hoogerwerf; J. J. Janse; A. R. Geelen; J. P. R. Koopman; R. D. Zwittink; J. J. Goeman; E. J. Kuijper; M. Roestenberg
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

A randomized controlled trial to investigate safety and variability of egg excretion after repeated controlled human hookworm infection.

The Journal of infectious diseases
2020-07 | Journal article
DOI: 10.1093/infdis/jiaa414
PMID: 32645714
Contributors: Hoogerwerf MA; Koopman JPR; Janse JJ; Langenberg MCC; van Schuijlenburg R; Kruize YCM; Brienen EAT; Manurung MD; Verbeek-Menken P; van der Beek MT et al.
Source: Self-asserted source
Jan Pieter Koopman via Europe PubMed Central
grade
Preferred source (of 2)‎

The Bacterial Gut Microbiota of Schoolchildren from High and Low Socioeconomic Status: A Study in an Urban Area of Makassar, Indonesia

Microorganisms
2020-06-26 | Journal article
DOI: 10.3390/microorganisms8060961
Contributors: Aldian I. Amaruddin; Firdaus Hamid; Jan Pieter R. Koopman; Munawir Muhammad; Eric A.T. Brienen; Lisette van Lieshout; Anoecim R. Geelen; Sitti Wahyuni; Ed J. Kuijper; Erliyani Sartono et al.
Source: check_circle
Crossref
grade
Preferred source (of 3)‎

A double-blind, placebo-controlled phase 1/2a trial of the genetically attenuated malaria vaccine PfSPZ-GA1.

Science translational medicine
2020-05 | Journal article
DOI: 10.1126/scitranslmed.aaz5629
PMID: 32434847
Contributors: Roestenberg M; Walk J; van der Boor SC; Langenberg MCC; Hoogerwerf MA; Janse JJ; Manurung M; Yap XZ; García AF; Koopman JPR et al.
Source: Self-asserted source
Jan Pieter Koopman via Europe PubMed Central
grade
Preferred source (of 2)‎

A controlled human Schistosoma mansoni infection model to advance novel drugs, vaccines and diagnostics.

Nature medicine
2020-02-17 | Journal article
DOI: 10.1038/s41591-020-0759-x
PMID: 32066978
Source: Self-asserted source
Jan Pieter Koopman
grade
Preferred source (of 3)‎

Katayama syndrome without schistosoma mansoni eggs

Annals of Internal Medicine
2019 | Journal article
DOI: 10.7326/L18-0438
EID:

2-s2.0-85066325746

Part of ISSN: 15393704 00034819
Contributors: Langenberg, M.C.C.; Hoogerwerf, M.-A.; Janse, J.J.; Van Lieshout, L.; Corstjens, P.L.A.M.; Roestenberg, M.; Van Dam, G.J.; Van Diepen, A.; De Dood, C.J.; Feijt, C. et al.
Source: Self-asserted source
Jan Pieter Koopman via Scopus - Elsevier

Risk assessment for the implementation of controlled human Schistosoma mansoni infection trials in Uganda [version 2; peer review: 2 approved]

2019-08-13 | Journal article
DOI: 10.12688/aasopenres.12972.2
Part of ISSN: 2515-9321
Contributors: Jan Pieter Koopman; Moses Egesa; Anne Wajja; Moses Adriko; Jacent Nassuuna; Gyaviira Nkurunungi; Emmanuella Driciru; Gijsbert van Willigen; Stephen Cose; Maria Yazdanbakhsh et al.
Source: check_circle
African Academy of Sciences (AAS) - Open Research
grade
Preferred source (of 2)‎

Urinary proteins, vitamin D and genetic polymorphisms as risk factors for febrile urinary tract infection and relation with bacteremia: a case control study.

PloS one
2015-03-25 | Journal article
DOI: 10.1371/journal.pone.0121302
PMID: 25807366
PMC: PMC4373833
Source: Self-asserted source
Jan Pieter Koopman
grade
Preferred source (of 2)‎

Peer review (1 review for 1 publication/grant)

Review activity for PLoS neglected tropical diseases (1)
How many people are using ORCID?